ClinicalTrials.gg
Sign In

Bone Diseases clinical trials

The registry lists 177 studies for Bone Diseases across more than 10 countries. 38 are recruiting or about to start. 40 of them are mainly about Bone Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 68 narrower conditions too, such as Osteoporosis: 8,512 studies, 1,676 open.

Get an email when these change. Save the Bone Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
93
Recruiting
26
Status unknown
20
Terminated
11
Active, not recruiting
10
Not yet recruiting
7

Phase

Phase 2
42
Phase 3
22
Phase 1
12
Phase 4
11
Early Phase 1
3

Where

United States
86
United Kingdom
35
France
31
Canada
30
Australia
27
Spain
26

Who runs them

Alexion Pharmaceuticals, Inc. (12) · BioMarin Pharmaceutical (10) · QED Therapeutics, a BridgeBio company (8) · Amgen (6) · Northwestern University (4) · National Institute of Dental and Craniofacial Research (NIDCR) (4) · National Heart, Lung, and Blood Institute (NHLBI) (4) · Hospices Civils de Lyon (3)

What is being tested here

Drugs under test in Bone Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Infigratinib325
Colchicine101
Testosterone 17 beta-cypionate111
Testosterone111
Finasteride111
Apixaban101
Narlumosbart111
Transdermal Estrogen101
Progesterone101
Apple cider vinegar101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 3 open

Coming up

9phase 3 studies under way
10studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10, phase 3 first

Who these studies take

Of the 26 Bone Diseases studies recruiting now, 10 (38%) set no upper age limit and 9 (35%) stop at 75 or younger. 12 (46%) take children under 18. 1 (4%) are for women only and 1 (4%) for men only; 2 (8%) take healthy volunteers.

Recruiting studies that take each age, of 26
AgeWomenMen
109 (35%)8 (31%)
1818 (69%)18 (69%)
3019 (73%)19 (73%)
4019 (73%)19 (73%)
5019 (73%)19 (73%)
6519 (73%)19 (73%)
7516 (62%)16 (62%)
8515 (58%)15 (58%)

Across all 177 studies, recruiting or not: 38% stop at 75 or younger and 32% at 65; 37% take children; 12% are for women only and 6% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Bone Diseases studies take

Of 19 phase 2 interventional studies under Bone Diseases, half reached primary completion within 43 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 243 mo29–66 · 19 studies——
Interventional, no phase22 mo10–54 · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 177. Browse all 177 → or search them.